Schedule 13G ownership disclosure
Immune Design Corp.
Security class unavailable · CUSIP: 45252L103
Event date: 2016-11-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-16-006171
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Nov 14, 2016
- Reporting period
- Nov 04, 2016
- Description
- Schedule 13G beneficial ownership